Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial

Karin Ribi; Weixiu Luo; Jürg Bernhard; Prudence A. Francis; Harold J. Burstein; Eva Ciruelos; Meritxell Bellet; Lorenzo Pavesi; Ana Lluch; Marilena Visini; Vani Parmar; Carlo Tondini; Pierre Kerbrat; Antonia Perelló; Patrick Neven; Roberto Torres; Davide Lombardi; Fabio Puglisi; Per Karlsson; Thomas Ruhstaller; Marco Colleoni; Alan S. Coates; Aron Goldhirsch; Karen N. Price; Richard D. Gelber; Meredith M. Regan; Gini F. Fleming

doi:10.1200/JCO.2015.64.8675

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial

Karin Ribi
, Weixiu Luo
, Jürg Bernhard
, Prudence A. Francis
, Harold J. Burstein
, Eva Ciruelos
, Meritxell Bellet
, Lorenzo Pavesi
, Ana Lluch
, Marilena Visini
, Vani Parmar
, Carlo Tondini
, Pierre Kerbrat
, Antonia Perelló
, Patrick Neven
, Roberto Torres
, Davide Lombardi
, Fabio Puglisi
, Per Karlsson
, Thomas Ruhstaller

Marco Colleoni, Alan S. Coates, Aron Goldhirsch, Karen N. Price, Richard D. Gelber, Meredith M. Regan, Gini F. Fleming

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	1601-1610
Fachzeitschrift	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Jahrgang	34
Ausgabenummer	14
DOIs	https://doi.org/10.1200/JCO.2015.64.8675
Publikationsstatus	Veröffentlicht - 10 Mai 2016
Extern publiziert	Ja

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Zugriff auf Dokument

10.1200/JCO.2015.64.8675

https://ascopubs.org/doi/10.1200/JCO.2015.64.8675

Dieses zitieren

Ribi, K., Luo, W., Bernhard, J., Francis, P. A., Burstein, H. J., Ciruelos, E., Bellet, M., Pavesi, L., Lluch, A., Visini, M., Parmar, V., Tondini, C., Kerbrat, P., Perelló, A., Neven, P., Torres, R., Lombardi, D., Puglisi, F., Karlsson, P., ... Fleming, G. F. (2016). Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34(14), 1601-1610. https://doi.org/10.1200/JCO.2015.64.8675

Ribi, Karin ; Luo, Weixiu ; Bernhard, Jürg et al. / Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial. in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 ; Jahrgang 34, Nr. 14. S. 1601-1610.

@article{94e871482c1c4234b3e9e0cb696cf61a,

title = "Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial",

author = "Karin Ribi and Weixiu Luo and J{\"u}rg Bernhard and Francis, \{Prudence A.\} and Burstein, \{Harold J.\} and Eva Ciruelos and Meritxell Bellet and Lorenzo Pavesi and Ana Lluch and Marilena Visini and Vani Parmar and Carlo Tondini and Pierre Kerbrat and Antonia Perell{\'o} and Patrick Neven and Roberto Torres and Davide Lombardi and Fabio Puglisi and Per Karlsson and Thomas Ruhstaller and Marco Colleoni and Coates, \{Alan S.\} and Aron Goldhirsch and Price, \{Karen N.\} and Gelber, \{Richard D.\} and Regan, \{Meredith M.\} and Fleming, \{Gini F.\}",

year = "2016",

month = may,

day = "10",

doi = "10.1200/JCO.2015.64.8675",

language = "English",

volume = "34",

pages = "1601--1610",

journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "14",

}

Ribi, K, Luo, W, Bernhard, J, Francis, PA, Burstein, HJ, Ciruelos, E, Bellet, M, Pavesi, L, Lluch, A, Visini, M, Parmar, V, Tondini, C, Kerbrat, P, Perelló, A, Neven, P, Torres, R, Lombardi, D, Puglisi, F, Karlsson, P, Ruhstaller, T, Colleoni, M, Coates, AS, Goldhirsch, A, Price, KN, Gelber, RD, Regan, MM & Fleming, GF 2016, 'Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Jg. 34, Nr. 14, S. 1601-1610. https://doi.org/10.1200/JCO.2015.64.8675

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial. / Ribi, Karin; Luo, Weixiu; Bernhard, Jürg et al.
in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Jahrgang 34, Nr. 14, 10.05.2016, S. 1601-1610.

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

TY - JOUR

T1 - Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial

AU - Ribi, Karin

AU - Luo, Weixiu

AU - Bernhard, Jürg

AU - Francis, Prudence A.

AU - Burstein, Harold J.

AU - Ciruelos, Eva

AU - Bellet, Meritxell

AU - Pavesi, Lorenzo

AU - Lluch, Ana

AU - Visini, Marilena

AU - Parmar, Vani

AU - Tondini, Carlo

AU - Kerbrat, Pierre

AU - Perelló, Antonia

AU - Neven, Patrick

AU - Torres, Roberto

AU - Lombardi, Davide

AU - Puglisi, Fabio

AU - Karlsson, Per

AU - Ruhstaller, Thomas

AU - Colleoni, Marco

AU - Coates, Alan S.

AU - Goldhirsch, Aron

AU - Price, Karen N.

AU - Gelber, Richard D.

AU - Regan, Meredith M.

AU - Fleming, Gini F.

PY - 2016/5/10

Y1 - 2016/5/10

U2 - 10.1200/JCO.2015.64.8675

DO - 10.1200/JCO.2015.64.8675

M3 - Article

SN - 0732-183X

VL - 34

SP - 1601

EP - 1610

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

IS - 14

ER -

Ribi K, Luo W, Bernhard J, Francis PA, Burstein HJ, Ciruelos E et al. Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Mai 10;34(14):1601-1610. doi: 10.1200/JCO.2015.64.8675